Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Kidney International

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.2001.00782.XPMID 11422747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate mofetil: therapeutic applications in kidney transplantation and immune-mediated renal disease.

  1999cited by this paper
• The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein.

  1999cited by this paper
• Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft.

  1999cited by this paper
• Kinetics of Doxorubicin Handling in the LLC-PK1 Kidney Epithelial Cell Line is Mediated by Both Vesicle Formation and P-glycoprotein Drug Transport

  1999cited by this paper
• Mycophenolate mofetil: therapeutic applications in kidney transplantation and immune-mediated renal disease.

  1999cited by this paper
• Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failure

  1999cited by this paper
• The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.

  1999cited by this paper
• P-glycoprotein expression is not a useful predictor of acute or chronic kidney graft rejection

  1999cited by this paper
• Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.

  1999cited by this paper
• Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15.

  1998cited by this paper
• MDR1 in taste buds of rat vallate papilla: functional, immunohistochemical, and biochemical evidence.

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• P Glycoprotein: A New Mechanism to Control Drug-Induced Nephrotoxicity

  1998cited by this paper
• Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells.

  1998cited by this paper
• Role of acute rejection in chronic rejection.

  1998cited by this paper
• Impact of acute rejection and early allograft function on renal allograft survival.

  1997cited by this paper
• Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules.

  1997cited by this paper
• Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.

  1997cited by this paper
• Identification of P-glycoprotein at the membrane of mast cell secretory granules. An immunofluorescence and protein A-gold electron microscopical investigation

  1997cited by this paper
• Molecular analyses of human renal allografts: differential intragraft gene expression during rejection.

  1997cited by this paper
• Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney.

  1997cited by this paper
• Acute rejection of renal allografts: mechanistic insights and therapeutic options.

  1997cited by this paper
• Chloride and Potassium Conductances of Mouse Pancreatic Zymogen Granules Are Inversely Regulated by a 80-kDa mdr1a Gene Product (*)

  1996cited by this paper
• Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans

  1996cited by this paper
• Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

  1996cited by this paper
• Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by a approximately 80-kDa mdr1a gene product.

  1996cited by this paper
• Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.

  1996cited by this paper
• A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.

  1996cited by this paper
• Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft.

  1995cited by this paper
• Chronic renal transplant loss.

  1995cited by this paper
• THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG‐TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2

  1994cited by this paper
• Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies.

  1994cited by this paper
• On structuring probabilistic dependences in stochastic language modelling

  1994cited by this paper
• International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

  1993cited by this paper
• Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody.

  1993cited by this paper
• Risk factors for chronic rejection in renal allograft recipients.

  1993cited by this paper
• Human P-glycoprotein transports cyclosporin A and FK506.

  1993cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.

  1993cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• Transplantation in the nineties.

  1992cited by this paper
• Transplantation in the nineties.

  1992cited by this paper
• Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.

  1992cited by this paper
• The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection.

  1991cited by this paper
• Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.

  1990cited by this paper
• Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

  1990cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective Study

  1986cited by this paper
• Chi-square tests with one degree of freedom

  1963cited by this paper

• Expression of drug transporters in human allogenic transplanted kidneys in acute rejection.

  2026cites this paper
• Calcineurin Inhibitor Associated Nephrotoxicity in Kidney Transplantation—A Transplant Nephrologist's Perspective

  2025cites this paper
• Unlocking the Rich Potential of a Soft Gel-Cream Enriched with Royal Jelly for Topical Use

  2025cites this paper
• Role of cyclosporin A in the treatment of kidney disease and nephrotoxicity.

  2023cites this paper
• Usefulness of 99mTc-SESTAMIBI Scintigraphy in Persistent Hyperparathyroidism after Kidney Transplant

  2021cites this paper
• Immune-Related Gene Polymorphisms and Pharmacogenetic Studies in Nephrology.

  2021cites this paper
• Hyperfluorescence Imaging of Kidney Cancer Enabled by Renal Secretion Pathway Dependent Efflux Transport

  2020cites this paper
• Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein

  2020cites this paper
• The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

  2020cites this paper
• Renal Secretion Pathway-dependent Efflux Transport Enabled Hyperfluorescence Imaging of Kidney Cancer.

  2020cites this paper
• Renal Secretion Pathway‐dependent Efflux Transport Enabled Hyperfluorescence Imaging of Kidney Cancer

  2020cites this paper
• ABC Family Transporters.

  2019cites this paper
• Renal tubular P-glycoprotein expression is reduced in plasma cell disorders

  2019influential citation
• Relationship between allograft cyclosporin concentrations and P‐glycoprotein expression in the 1st month following renal transplantation

  2019cites this paper
• Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical 99mTc-MIBI

  2017cites this paper
• Pharmacogénétique des immunosuppresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

  2017cites this paper
• P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids.

  2017cites this paper
• Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).

  2017cites this paper
• Kidney Fibrosis: Origins and Interventions.

  2017cites this paper
• Strategies to optimize tacrolimus treatment and improve long-term clinical outcomes in solid organ transplantation

  2016influential citation
• Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study

  2016cites this paper
• Changes in ABCB1 mRNA Expression in Peripheral Blood Cells before and after Renal Transplantation.

  2016cites this paper
• Imaging physiological ABC transporter expression and its relation to disease using Tc-99m-hexakis-methoxy-isobutyl isonitrile (Tc-99m-MIBI)

  2015influential citation
• Radiopharmaceuticals for the Imaging of ABC-Transporter-Mediated Multidrug Resistance in Cancer

  2015cites this paper
• Mammalian Target of Rapamycin Inhibitors and Nephrotoxicity: Fact or Fiction.

  2015cites this paper
• Phosphodiesterase type 5 inhibition attenuates cyclosporine A induced nephrotoxicity in mice

  2015influential citation
• Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

  2014cites this paper
• Université de Montréal-Thèse numérique

  2014cites this paper
• Impact of ABC transporters on secondary fungal metabolites as remedies or toxins

  2014cites this paper
• Old tracer for a new purpose: potential role for 99mTc-2-methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care

  2014cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• Cellular Mechanisms of Drug Nephrotoxicity

  2013cites this paper
• Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats

  2012cites this paper
• The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis.

  2012cites this paper
• Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.

  2012cites this paper
• Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation.

  2012cites this paper
• ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation.

  2012influential citation
• Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation

  2012cites this paper
• Imaging of multidrug resistance in cancer

  2011cites this paper
• Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.

  2011cites this paper
• Use of pharmacogenomics in psoriasis

  2011cites this paper
• Expression of CYP3A5 and P-glycoprotein in Renal Allografts With Histological Signs of Calcineurin Inhibitor Nephrotoxicity

  2011cites this paper
• Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine

  2011cites this paper
• The Latest Advances in Pharmacogenetics and Pharmacogenomics in the Treatment of Psoriasis

  2010cites this paper
• Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach.

  2010cites this paper
• Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis

  2010cites this paper
• Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure.

  2010cites this paper
• Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

  2010cites this paper
• Up-regulation of renal Mdr1 and Mrp2 transporters during amiodarone pretreatment in rats.

  2010cites this paper
• The Pharmacogenetics of Calcineurin Inhibitor–Related Nephrotoxicity

  2010influential citation
• Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice

  2010cites this paper
• Balancing efficacy and toxicity of kidney transplant immunosuppression.

  2009cites this paper
• Calcineurin inhibitor nephrotoxicity.

  2009cites this paper
• CYP3A5 and ABCB1 genes and hypertension.

  2009cites this paper
• Identification de marqueurs phénotypiques et génétiques influençant la réponse au traitement et le pronostic des patients atteints d'insuffisance cardiaque

  2009cites this paper
• Allograft biopsies: studying them for all they're worth.

  2009cites this paper
• Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living‐related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia

  2009cites this paper
• Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

  2009cites this paper
• Albumin influences expression and function of the membrane transporter P-glycoprotein in HK-2 human proximal tubular cells.

  2009cites this paper
• Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin?

  2009cites this paper
• Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.

  2008cites this paper
• Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.

  2008cites this paper
• Association of ABCB1 genetic variants with renal function in Africans and in Caucasians

  2008cites this paper
• Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.

  2008cites this paper
• Pharmacogenetics in solid organ transplantation: current status and future directions.

  2008cites this paper
• Biotransformation Enzymes and Drug Transporters Pharmacogenetics in Relation to Immunosuppressive Drugs: Impact on Pharmacokinetics and Clinical Outcome

  2008cites this paper
• Suppressive potencies of calcineurin inhibitors against the mitogen‐induced blastogenesis of peripheral‐blood mononuclear cells of myasthenia gravis patients

  2008cites this paper
• Nephrotoxicity of calcineurin and mTOR inhibitors

  2008cites this paper
• CHAPTER 87 – Cellular Mechanisms of Drug Nephrotoxicity

  2008cites this paper
• La génétique de l'hypertension: rôle des gènes CYP3A5 et ABCB1 dans le contrôle de la tension artérielle

  2008cites this paper
• The Evolution of Nonimmune Histological Injury and Its Clinical Relevance in Adult‐Sized Kidney Grafts in Pediatric Recipients

  2007cites this paper
• Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine.

  2007cites this paper
• Association of cumulative cyclosporine dose with its irreversible nephrotoxicity in Japanese patients with pediatric-onset autoimmune diseases.

  2007cites this paper
• Tacrolimus Exposure and Evolution of Renal Allograft Histology in the First Year After Transplantation

  2007influential citation
• Potential role of fractalkine receptor expression in human renal fibrogenesis.

  2007cites this paper
• Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.

  2007influential citation
• Individualisation of mycophenolate mofetil therapy

  2007cites this paper
• Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

  2006cites this paper
• Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction.

  2006cites this paper
• Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes.

  2006cites this paper
• Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis

  2006cites this paper
• ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.

  2005cites this paper
• Comparative Study on the Effects of Cyclosporin A in Renal Cells in Culture

  2005cites this paper
• Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance‐Associated Protein 2

  2005cites this paper
• The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

  2005cites this paper
• Strategies for minimizing immunosuppression in kidney transplantation

  2005cites this paper
• Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P‐glycoprotein

  2005influential citation
• Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expression

  2004cites this paper
• Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.

  2004cites this paper
• MDR1 mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Ulcerative Colitis in Relation to Glucocorticoid Administration

  2004cites this paper
• Time-Related Clinical Determinants of Long-Term Tacrolimus Pharmacokinetics in Combination Therapy with Mycophenolic Acid and Corticosteroids

  2004cites this paper
• Low-dose cyclosporine with mycophenolate mofetil induces similar calcineurin activity and cytokine inhibition as does standard-dose cyclosporine in stable renal allografts.

  2004cites this paper
• Cyclosporine nephrotoxicity.

  2003cites this paper
• Pharmacological aspects of nephrotoxicity

  2003cites this paper
• Renal handling of drugs and xenobiotics

  2003cites this paper
• Calcineurin inhibitors and sirolimus

  2003cites this paper
• Evaluation of P‐glycoprotein—Mediated Renal Drug Interactions in an MDR1‐MDCK Model

  2003cites this paper
• Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy.

  2002cites this paper
• Dialysis and Transplantation

  2001cites this paper
• Renal medicine and renal transplantation

  2000cites this paper